Tag: mathematics
-
A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds
A company developing area sensors for smart homes that combine WiFi technology with machine learning algorithms is raising $10.5 million in venture funds.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Infographic – U.S. Public Backs A.I. Regulation
A recent survey shows a solid bipartisan majority of U.S. adults favors at least some government regulation of artificial intelligence, including people who say they use A.I.
-
Automated Life Science A.I. Generation System Unveiled
A bioengineering lab created a system to make it easier for life scientists to use machine learning for data analysis, without writing their own algorithms.
-
Crop Health Device Company Raises $3.5M in Early Funds
A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round.
-
Neuro Biomarkers, Home EEG Assessed in Upcoming Trial
A digital biomarkers company and developer of neuroscience analytics are collaborating on a study of EEG measurements and algorithms with a wearable device at home.
-
Companies Partner on A.I., Fusion Energy for Space Flight
A developer of fusion energy for space travel and software company for space flight systems are writing machine learning algorithms to design a hyper-fast rocket engine.
-
Infographic – Top A.I. Work Impact Expected in Financial Services
Generative artificial intelligence is expected to affect more work processes in banking and insurance than other industries, according to a recent study.
-
Primate Genome A.I. Model IDs Human Disease Variants
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans.
-
AI-Designed Cancer Vaccine Shown to Act Against Melanoma
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors.